Bill > A01461

This bill establishes new regulations for the use of antipsychotic medications in nursing homes, requiring informed written consent before administration with several specific exceptions. The bill defines key terms like "lawful representative" (someone authorized to consent on behalf of a resident who lacks capacity) and outlines detailed disclosure requirements when seeking consent, including explaining the medication's purpose, anticipated benefits, potential side effects, alternative treatments, and the resident's right to refuse or revoke consent. For situations where a resident lacks capacity and has no lawful representative, the bill provides a process for medication authorization. The bill also allows for emergency use of antipsychotic medications without consent when necessary to protect the life, health, or safety of the resident or others, with requirements that such emergency use be immediately documented and relevant parties notified. Healthcare professionals must document the consent process, including date, time, and to whom information was provided. The bill includes provisions for notifying family members about medication orders when requested, unless the resident specifically objects. The legislation will take effect one year after becoming law, and the commissioner is authorized to create implementing regulations.

Health and Social Services, Housing and Urban Affairs

https://www.nysenate.gov/legislation/bills/2025/A1461